Thrombopoietin Levels of Thrombocytopenic Term and Preterm Newborns with Infection

ABSTRACT

We measured Thrombopoietin (Tpo) levels in thrombocytopenic term and preterm babies with infection to investigate the relationship between thrombopietin levels and platelet counts. Sixteen preterm (27-34 weeks' gestational age) and 5 term neonates (38-41 weeks' gestational age) with the diagnosis of neonatal infection and thrombocytopenia (platelets <150 × 10⁹/L) but, without the evidence of disseminated intravascular coagulation, were prospectively enrolled in the study. Fifteen preterm (27-34 weeks' gestational age) and 9 term (38-40 weeks' gestational age) age-matched healthy neonates were enrolled in the study as control. Blood samples were obtained from each subject at the time when infection and thrombocytopenia were detected and stored until assay. Bacterial infection was confirmed by blood cultures in five patients and by tracheal cultures in five. Median Tpo levels of term controls were lower than those of preterm controls (62 pg/mL vs. 87 pg/mL) (p <0.05). Median Tpo levels of thrombocyopenic preterm patients were higher than the levels of healthy preterms (258 pg/mL vs. 87 pg/mL) (p <0.05). Similarly, median Tpo levels of sick terms were significantly higher than those of healthy term controls (209 pg/mL vs. 62 pg/mL) (p <0.001). There was not significant difference between the median Tpo levels of term and preterm babies with infection (258 pg/mL vs. 209 pg/mL) (p >0.05). There was no correlation between platelet counts and Tpo levels in both term and preterm groups. The results of our study show that healthy term and preterm babies have detectable levels of Tpo and preterm babies have higher Tpo levels than term infants. Although thrombocytopenic babies with infection have increased levels of Tpo, these levels are still lower than the levels of thrombocytopenic children/adult patients and there seems to be no correlation between platelet counts and thrombopoietin levels. So our observation of increased Tpo levels may still be inadequate for normal platelet production in this period. and this group of babies may also be candidates for the administration of recombinant human Tpo.

KEYWORD

Thrombopoietin - thrombocytopenia - newborn

REFERENCES

• 1 Nishihira H, Toyoda Y, Miyazaki H, Kigasawa H, Ohsaki E. Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies.  Br J Haematol . 1996;  1 23-28
• 2 Murray N A, Roberts I A. Circulating megakaryocytes and their progenitors (BFU-MK and CFU-MK) in term and preterm neonates.  Br J Haematol . 1995;  1 41-46
• 3 Metha P, Rohitkumar V, Neumann L, Karpatkin M. Thrombocytopenia in the high risk infant.  J Pediatr . 1980;  97 791-794
• 4 Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia.  J Pediatr . 1986;  1 749-755
• 5 Tate D Y, Carlton G T, Johnson D. Immune thrombocytopenia in severe neonatal infections.  J Pediatr . 1981;  3 449-453
• 6 Broudy V C, Kaushansky K. Biology of thrombopoietin.  Curr Opin Pediatr . 1998;  10 60-64
• 7 Ramsfjell V, Borge O J, Veiby O P. Thrombopoietin, but not erithropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.  Blood . 1996;  88 4481-4492
• 8 Kaushansky K. Thrombopoietin: the primary regulator of platelet production.  Blood . 1995;  86 419-431
• 9 Franklin D Z, Kaushansky K. Effect of thrombopoietin on the development of megakaryocytes and platelets: an ultrastructural analysis.  Blood . 1996;  88 1632-1638
• 10 Emmons R VB, Reid D M, Cohen R L. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.  Blood . 1996;  87 4068-4071
• 11 Vadhan-Raj S, Murray U, Bueso-Ramos C. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in cancer patients.  Ann Intern Med . 1997;  126 673-681
• 12 Tahara T, Usuki K, Sato H. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders.  Br J Haematol . 1996;  4 783-788
• 13 Kuter D J, Rosenberg R D. The resiprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during Busulf-induced thrombocytopenia in the rabbit.  Blood . 1995;  85 2720-2730
• 14 Broudy V C, Lin N L, Sabath D F, Papayannopoulou T, Kaushansky K. Human platelets display high-affinity receptors for thrombopoietin.  Blood . 1997;  89 1896-1904
• 15 Fielder P J, Hass P, Nagel M. Human platelets as a model for the binding and degradation of thrombopoietin.  Blood . 1997;  89 2787-2788
• 16 Murray N A, Watts T L, Roberts I AG. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies.  Pediatr Res . 1998;  43 148-151
• 17 Watts T L, Murray N A, Roberts I A. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies.  Pediatr Res . 1999;  1 28-32
• 18 Sola M C, Christensen R D, Hutson A D, Tarantal A F. Pharmacokinetics, pharmacodynamics, and safety of administring pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys.  Pediatr Res . 2000;  47 208-214
• 19 Israels S J. Thrombopoietin and neonatal thrombocytopenia.  Pediatr Res . 2000;  47 176-177
• 20 Albert T SE, Meng Y G, Simms P, Cohen R L, Phibbs R H. Thrombopoietin in the thrombocytopenic term and preterm newborn.  Pediatrics . 2000;  105 1286-1291
• 21 Colarizi P, Fiorucci P, Caradonna A, Ficuccilli F, Mancuso M, Papoff P. Circulating thrombopoietinlevels in neonates with infection.  Acta Paediatr . 1999;  88 332-337
• 22 Tollner U. Early diagnosis of septicemia in the newborn: clinical studies and sepsis score.  Eur J Pediatr . 1982;  138 331-338
• 23 Sola M C, Vecchio A D, Rimsza L M. Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit.  Clin Perinatol . 2000;  27 655-679
• 24 Murray N A, Watts T L, Roberts I AG. Inhibition of megakaryocytopoiesis in ``late'' sepsis-associated thrombocytopenia in preterm babies.  Blood . 1999;  94 450a
• 25 Shivdasani R A, Fielder P, Keller G A, Orkin S H, Sauvage F J. Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice.  Blood . 1997;  90 1821-1827